Drug General Information
Drug ID
D0M8AR
Former ID
DNC013510
Drug Name
1-(5-phenyloxazol-2-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529594]
Structure
Download
2D MOL

3D MOL

Formula
C27H39NO2
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=C2
InChI
1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(29)27-28-23-26(30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9-
InChIKey
JBJNKCWDUQMEEA-KTKRTIGZSA-N
PubChem Compound ID
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529594]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.